Implanting living cells as long-term drug producers could transform treatment for numerous diseases, but it is difficult to house the tiny workers in quantities high enough to ensure dosage needs are ...

The field of biosensor technology is undergoing rapid transformation, driven by the need for precise, real-time monitoring of biochemical processes such as ...

Soil salinity is a critical concern in agriculture when excessive soluble salts restrict a plant's water uptake, according to ...

A driver’s frustrating check-engine saga is making the rounds after a repair estimate swung from “brace yourself” to “that’ll ...

It is where AI faces its hardest test: layers of regulation, life-or-death stakes, complex biology, and a deeply human, ...

Upstream Bio Inc. (NASDAQ: UPB) shares are trading lower during Friday’s session as the stock reacts to recent developments in its clinical trials. Over the last few days, the stock has plunged more ...

Upstream Bio (UPB) lost ~12% in the premarket on Wednesday even after the company said that a mid-stage trial for its experimental asthma therapy, verekitug, succeeded, paving the way for the drug's ...

Despite the selloff, Upstream Bio plans to advance verekitug into Phase 3 trials for both severe asthma and chronic rhinosinusitis with nasal polyps (CRSwNP) following regulatory interactions. The ...

WALTHAM, Mass., Feb. 11, 2026 (GLOBE NEWSWIRE) -- Upstream Bio, Inc. (Nasdaq: UPB), a clinical-stage company developing treatments for inflammatory diseases, with an initial focus on severe ...

In a statement sent to Rigzone by the Enverus team recently, Enverus subsidiary Enverus Intelligence Research (EIR) said U.S. upstream M&A “regained momentum” in the fourth quarter of 2025. “After a ...

Let’s face it: As we age, our vision and balance aren’t what they used to be. These changes to our senses can be minor annoyances but can also lead to injury, from stubbed toes to serious falls.